5:21 PM ET
8-K
Other 8-K Filing
Lakewood-Amedex Biotherapeutics Other 8-K Filing
Lakewood-Amedex Biotherapeutics entered into a Share Redemption Agreement to redeem all 127,097 outstanding shares of its Series C Convertible Preferred Stock for $1.27 million in cash. The transaction simplifies the company's capital structure, eliminates potential dilution from future conversions, and removes associated financing restrictions.
- Counterparty
- Shakawe Capital LLC